-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
InMed Pharmaceuticals Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q2 2021 to Q2 2022.
- InMed Pharmaceuticals Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending June 30, 2022 was $18.7M, a 33.7% increase year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)